Stocksigma LogoStocksigma Logo

Jubilant Pharmova Receives ICRA AA+ Stable Rating for Rs 1,400 Crore NCDs

ICRA Limited assigned an [ICRA]AA+ rating with a Stable outlook to Jubilant Pharmova Limited's proposed Non-Convertible Debenture (NCD) programme amounting

Jubilant Pharmova Receives ICRA AA+ Stable Rating for Rs 1,400 Crore NCDs

Jubilant Pharmova Ltd 路 Others (Uncategorized) 路 14 Oct 2026, 10:01 pm

Jubilant Pharmova Receives ICRA AA+ Stable Rating for Rs 1,400 Crore NCDs ICRA Limited assigned an [ICRA]AA+ rating with a Stable outlook to Jubilant Pharmova Limited's proposed Non-Convertible Debenture (NCD) programme amounting to Rs 1,400.00 crore. The rating communication was received by the company on 13th Oct'26. The assigned credit rating remains valid throughout the life of the instrument once issued, reflecting strong creditworthiness for the company's planned debt issuance.

Original exchange filing (PDF)

More announcements from Jubilant Pharmova Ltd

All Jubilant Pharmova Ltd announcements